Abstract:figure legend Circulating noradrenaline (NA) stimulates the release of neuropeptide Y (NPY) from presynaptic sympathetic nerve terminals via activation of β‐adrenergic receptors (β‐R). This NA‐induced NPY release can be inhibited by the β‐blocker propranolol, suggesting that this mechanism, which enhances sympathoexcitation, is mediated via β‐adrenergic receptors. Cardiac disease is marked by sympathoexcitation and elevated levels of noradrenaline (NA) and cotransmitter neuropeptide Y (NPY). Increased NPY levels are associated with a greater risk of ventricular arrhythmias and mortality. Nonetheless, the factors that cause NPY release remain poorly understood. We hypothesized that circulating catecholamines might lead to NPY release from myocardial sympathetic nerve terminals via a β‐receptor‐mediated mechanism that enhances sympathoexcitation. Ventricular interstitial NA and NPY levels were measured in six Yorkshire pigs after i.v. administration of NA (1 mg) and before and after propranolol infusion (1 mg/kg). Real‐time interstitial NPY levels were measured using ventricular capacitive immunoprobes (CIs) affixed with NPY antibodies and quantified as the change in CI input current (INPY) upon binding of NPY. Interstitial NA was measured with adjacent fast‐scan cyclic voltammetry probes (INA). A left ventricular pressure catheter and continuous ECGs were used for haemodynamic recordings, and an epicardial 56‐electrode sock was used for measurements of activation recovery interval, a surrogate of action potential duration. Upon administration of NA, heart rate and left ventricular pressure increased, and activation recovery interval shortened. Notably, NA significantly increased interstitial myocardial NPY levels. After propranolol, changes in heart rate and activation recovery interval were largely mitigated. The INA increased to a similar extent post‐propranolol vs. pre‐propranolol, but changes in INPY were significantly reduced post‐propranolol. Coronary sinus plasma analyses confirmed fast‐scan cyclic voltammetry and CI findings. Hence, this study demonstrates that circulating NA induces NPY release from ventricular sympathetic nerve terminals, the mechanism for which is mediated via β‐adrenergic receptors and can be blocked by the non‐selective β‐blocker, propranolol. Key points Cardiovascular disease is characterized by sympathovagal imbalance, with increased plasma noradrenaline (NA) and neuropeptide Y (NPY) concentrations. Increased NPY levels are associated with increased ventricular arrhythmias and mortality in heart failure. Limited data are available on the specific factors that cause NPY release. In this study, fast‐scan cyclic voltammetry and capacitive immunoprobes were used to allow for real‐time in vivo measurements of interstitial myocardial neurotransmitters and neuropeptides, respectively. Using an in vivo porcine model with cardiac fast‐scan cyclic voltammetry and capacitive immunoprobes, it was shown that systemic NA can increase ventricular interstitial NPY levels, suggesting that NA induces NPY release from postganglionic sympathetic nerves. The release of NPY was blocked by administration of the non‐selective β‐blocker propranolol, suggesting that release of NPY is dependent on activation of β‐adrenergic receptors by NA.

Quality mobility care in nursing homes: a model of moderating and mediating factors to guide intervention development.

A fast spatial partition method in bounding volume hierarchy

Early and late-onset pre-eclampsia.

Hemodynamic, hormonal, and renal actions of adrenomedullin 2 in experimental heart failure

Determination of 7-(2-hydroxyethyl)guanine with gas chromatography/mass spectrometry as a parameter for genotoxicity of ethylene oxide.

Sympathetic transduction of cardiac sympathetic nerve activity in healthy, conscious sheep

Adrenomedullin 2 microinjection into the nucleus tractus solitarius elevates arterial pressure and heart rate in rats

Effect of Adrenomedullin 2 on Blood Pressure and Heart Function in SHR

Protection from gentamicin ototoxicity by iron chelators in guinea pig in vivo.

Adrenomedullin and central cardiovascular regulation

Central actions of adrenomedullin on cardiovascular parameters and sympathetic outflow in conscious rats

Effects of adrenomedullin 2 on regional hemodynamics in conscious rats

Potentiated Response to Adrenomedullin in Myocardia and Aortas in Spontaneously Hypertensive Rat

Adrenomedullin microinjection into the area postrema increases blood pressure.

Adrenomedullin2 in SHR

Adenosine A(2A)R Modulates Cardiovascular Function by Activating ERK1/2 Signal in the Rostral Ventrolateral Medulla of Acute Myocardial Ischemic Rats.

Circulating noradrenaline leads to release of neuropeptide Y from cardiac sympathetic nerve terminals via activation of β‐adrenergic receptors

bcl‐2, p53 immunophenotypes and apoptosis in squamous cell carcinoma of the oesophagus

Cerebellar Adrenomedullinergic System. Role in Cardiovascular Regulation

Impact of Nitric Oxide on Adrenomedullin- and Proadrenomedullin N-terminal 20 Peptide-Induced Cardiac Responses: Action by Alone and Combined Administration

Effect of Long‐Term Treatment with Massive Doses of 1α‐Hydroxyvitamin D3 on Calcium‐Phosphate Balance in Patients with Vitamin D‐Dependent Rickets Type II